CD274 and T-cell non-Hodgkin lymphoma: Furthermore, in addition to the satisfactory anti-tumor activity observed on T cell lymphoma, low or not significant cardiotoxic side effects were observed when the combination of LAG-3_1 and PD-L1_1 was tested on cardiomyocytes co-cultured with hPBMCs (data not shown).